The Patent Finder

Lynkeus Biotech GmbH

Also on record
Records under this name other than patents Lynkeus Biotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Lynkeus Biotech GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,202,845Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
Formerly held
Term ended
Ended no later than Apr 16, 2023 · Medium confidence
Term endedEnded no later than Apr 16, 2023Medium confidence
US 8,946,180Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
Formerly held
Lapsed on the fee record
Ended Feb 3, 2023 · High confidence
Lapsed on the fee recordEnded Feb 3, 2023High confidence
US 6,410,314Episomally replicating vector, its preparation and use
Formerly held
Lapsed on the fee record
Ended Jun 25, 2010 · USPTO record
Lapsed on the fee recordEnded Jun 25, 2010USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited